Federal agencies that regulate drug pricing and healthcare insurance are concerned that an industry practice of using rebates to lower drug costs for insurers has led to increases in list prices and out-of-pockets costs for ...
Jun 15, 2021
0
4
The Boston area has long been home to innovation that leads to impactful new drugs. But manufacturing those drugs for clinical trials often involves international partners and supply chains. The vulnerabilities of that system ...
Jun 11, 2021
0
2
After years of disappointing studies of potential treatments for the more than 6 million people living with Alzheimer's disease, the U.S. Food and Drug Administration recently approved a new drug called aducanumab that is ...
Jun 09, 2021
0
3
Two articles published online today by Alzheimer's & Dementia: Translational Research & Clinical Interventions, a journal of the Alzheimer's Association, show substantial changes in the focus and funding of clinical trials ...
May 25, 2021
0
1
An expert panel convened by the Alzheimer's Drug Discovery Foundation (ADDF) and The Association for Frontotemporal Degeneration (AFTD) provides guidance on best practices for the design of early drug trials for Alzheimer's ...
May 18, 2021
1
6
A program that provides ongoing support to patients with painful conditions and complex medication regimens may also help them avoid using potentially risky opioid pain medications, or reduce the amount they use, a new study ...
May 06, 2021
0
2
The European Commission proposed Thursday that EU nations join forces to develop and deploy COVID-19 drugs across the 27-nation bloc.
May 06, 2021
0
3
Determining safe yet effective drug dosages for children is an ongoing challenge for pharmaceutical companies and medical doctors alike. A new drug is usually first tested on adults, and results from these trials are used ...
May 06, 2021
0
0
A Yale-led study reveals that new medicines and vaccines approved for use in the United States are often unavailable in countries that hosted their clinical trials, suggesting that the benefits of drug research are not being ...
May 06, 2021
0
12
When drug manufacturers raise the list price for brand-name prescription drugs, do patients' out-of-pocket costs rise too? A new study published in JAMA Network Open by Dr. Benjamin Rome and colleagues in the Brigham's Division ...
May 04, 2021
0
0
